EW vs NOMA · P/E 47, rev $3.39B vs rev $6.4K
Edwards Lifesciences Corp (EW) versus NOMADAR Corp. Class A Common Stock (NOMA) — a side-by-side from cached financials, not a winner call.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
NOMADAR Corp. Class A Common Stock (NOMA) is a leisure company listed on NASDAQ.
Latest reported EW revenue for 2026-06-30 was $3.39B. Net income was $622.6M. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Latest reported NOMA revenue for 2025-12-31 was $6.4K. Net income was -$2.8M. Revenue was down 20.5% from 2024-12-31 to 2025-12-31. NOMA currently screens at market cap $58.4M.
EW currently screens at market cap $49.91B and trailing P/E 46.9. NOMA currently screens at market cap $58.4M.
Not investment advice. Open the EW and NOMA stock pages for the full models.
Not investment advice.